Charities launch appeal to reverse Nice decision on life-saving cancer treatment - Blood Cancer UK, Lymphoma Action and stem cell charity Anthony Nolan have formally appealed against the decision.
The FDA has granted fast track designation to LBL-034 for patients with relapsed or refractory multiple myeloma. The U.S.
HANGZHOU, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- The global chemical industry continues to face ...
Fury over decision to axe ‘last hope’ cancer treatment from NHS - It’s being called a ‘backward step for NHS care’ ...
Market valued at $76.50B in 2024, projected 9.75% CAGR growth driven by aerospace CMCs, EV batteries, semiconductor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results